
Mark Blumenthal
3
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 16, 2026
Lesson 32: Interview with Industry Legend: Mark Blumenthal
13:34
13:48
13:54

Mark BlumenthalGUEST
Thank you for being old enough and committed and connected enough to us to remember those days when Herb Clip was mailed out by snail mail on paper.

Mark BlumenthalGUEST
And some of you entrepreneur types that may be watching or listening may take note on this.

Mark BlumenthalGUEST
Necessity being the mother of invention and all of that hackneyed trite stuff.
18 MINS LATER
ENCORE: From Teas to Capsules: Exploring Botanical Breakthroughs, Part 1
10:36
10:50
10:58
R
10:27Ronald HoffmanHOST
What say you? I think your organization, the American Botanical Council, and some of the projects that you've undertaken is sort of the best retort to that argument, isn't it?

Mark BlumenthalGUEST
Yeah, I mean, first of all, let me just say there's a lot of good companies that are run by ethical people that are responsible, that care about the quality of the ingredients they put in their products.

Mark BlumenthalGUEST
And ultimately, they care about a beneficial effect and overall benefit for the health community.

Mark BlumenthalGUEST
And yet there's also people out there who are more concerned about the business and making money and less concerned about the quality.
5 MINS LATER
ENCORE: From Teas to Capsules: Exploring Botanical Breakthroughs, Part 2
7:37
7:43
7:50
8:05
R
7:25Ronald HoffmanHOST
So it's not like a blanket refusal to use these things as adjuncts to conventional medicines or surgeries.

Mark BlumenthalGUEST
And what we do actually is look at the medical and clinical and scientific literature, mainly clinical.

Mark BlumenthalGUEST
We don't get into the chemical studies and the animal studies because there's thousands of those published every year.

Mark BlumenthalGUEST
And there's been an explosion, by the way, in the last 30 or 40 years in research, scientific research from chemistry, pharmacology, toxicology and human clinical studies.

Mark BlumenthalGUEST
growth in the number of papers being published every year, new journals popping up, etc., and of papers of various qualities, designs, etc., and journals with various levels of quality as far as their peer review, etc.
11 MINS LATER
